Innate Pharma SA
OTC:IPHYF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Innate Pharma SA
OTC:IPHYF
|
FR |
|
W
|
Westshore Terminals Investment Corp
F:3I7
|
CA |
|
A
|
Auxly Cannabis Group Inc
SWB:3KF
|
CA |
|
Nilorngruppen AB
F:1GG
|
SE |
|
R
|
RBC Bearings Inc
F:B1X
|
US |
|
VNET Group Inc
NASDAQ:VNET
|
CN |
|
Eros Media World PLC
F:E1O
|
AE |
|
Auction Technology Group PLC
F:684
|
UK |
|
PTT PCL
OTC:PUTRY
|
TH |
|
M
|
Miss Grand International PCL
SET:MGI
|
TH |
|
E
|
Eros Media World PLC
XBER:E1O
|
AE |
|
R
|
Race Oncology Ltd
OTC:RAONF
|
AU |
|
H
|
Hologic Inc
XMUN:HO1
|
US |
|
PTT PCL
SET:PTT
|
TH |
|
Cooper Energy Ltd
ASX:COE
|
AU |
|
Innate Pharma SA
NASDAQ:IPHA
|
FR |
|
McPherson's Ltd
F:M5C
|
AU |
|
S
|
Smart Digital Group Ltd
NASDAQ:SDM
|
SG |
|
Turk Hava Yollari AO
F:TU5A
|
TR |
|
K
|
Kwesst Micro Systems Inc
XTSX:DFSC
|
CA |
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
D
|
Dhunseri Ventures Ltd
BSE:523736
|
IN |
Wall St Price Targets
IPHYF Price Targets Summary
Innate Pharma SA
According to Wall Street analysts, the average 1-year price target for IPHYF is 5.67 USD with a low forecast of 4.72 USD and a high forecast of 6.76 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IPHYF's stock price target?
Price Target
5.67
USD
According to Wall Street analysts, the average 1-year price target for IPHYF is 5.67 USD with a low forecast of 4.72 USD and a high forecast of 6.76 USD.
What is the Revenue forecast for Innate Pharma SA?
Projected CAGR
174%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 3 years is 174%.
What is the Gross Profit forecast for Innate Pharma SA?
Projected CAGR
1 086%
The compound annual growth rate for Gross Profit over the next 3 years is 1 086%.
